Distribution of leukemia subtypes
Diagnosis . | No.(%) . |
|---|---|
| AML | |
| Total | 620 (66) |
| t(15;17) | 42 (4) |
| t(8;21) | 38 (4) |
| inv(16)/t(16;16) | 49 (5) |
| t(11q23) | 47 (5) |
| Complex aberrant | 75 (8) |
| Other abnormalities | 176 (19) |
| Normal karyotype | 193 (21) |
| ALL | |
| Total | 152 (16) |
| Pro-B-ALL with t(11q23) | 26 (3) |
| c-ALL/pre-B-ALL with t(9;22) | 42 (4) |
| c-ALL/pre-B-ALL without t(9;22) | 40 (4) |
| Mature B-ALL with t(8;14) | 12 (1) |
| Cortical T-ALL | 20 (2) |
| Immature T-ALL | 12 (1) |
| CML, chronic phase | 75 (8) |
| CLL | 45 (5) |
| Nonleukemia | 45 (5) |
Diagnosis . | No.(%) . |
|---|---|
| AML | |
| Total | 620 (66) |
| t(15;17) | 42 (4) |
| t(8;21) | 38 (4) |
| inv(16)/t(16;16) | 49 (5) |
| t(11q23) | 47 (5) |
| Complex aberrant | 75 (8) |
| Other abnormalities | 176 (19) |
| Normal karyotype | 193 (21) |
| ALL | |
| Total | 152 (16) |
| Pro-B-ALL with t(11q23) | 26 (3) |
| c-ALL/pre-B-ALL with t(9;22) | 42 (4) |
| c-ALL/pre-B-ALL without t(9;22) | 40 (4) |
| Mature B-ALL with t(8;14) | 12 (1) |
| Cortical T-ALL | 20 (2) |
| Immature T-ALL | 12 (1) |
| CML, chronic phase | 75 (8) |
| CLL | 45 (5) |
| Nonleukemia | 45 (5) |